Article info
PDFState of the art review
β-Blockers, heart disease and COPD: current controversies and uncertainties
- Correspondence to Professor Jillian G Baker, Respiratory Medicine, Cell Signalling, School of Life Sciences, C Floor Medical School, Queen's Medical Centre, University of Nottingham, Nottingham NG11 2UH, UK; jillian.baker{at}nottingham.ac.uk
Citation
β-Blockers, heart disease and COPD: current controversies and uncertainties
Publication history
- Received May 10, 2016
- Revised October 14, 2016
- Accepted October 21, 2016
- First published December 7, 2016.
Online issue publication
September 01, 2022
Article Versions
- Previous version (15 February 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/